title: Indications and strategies for continuing GH treatment during transition from late adolescence to early adulthood in patients with GH deficiency: the impact on bone mass.
abstract: GH plays an important role in longitudinal bone growth and maturation during childhood and adolescence. However, GH has important metabolic functions other than bone growth, which become more apparent during young adulthood, when growth has been completed. Indeed, GH deficiency (GHD) in adult life is a recognized clinical syndrome which includes symptoms such as increased central adiposity, decreased lean body mass, reduced bone mineral density (BMD), increased atherogenic risk, cerebrovascular and cardiac morbidity and mortality, and reduced quality of life. As approximately one quarter of the children with GHD should continue GH administration in adulthood, it is important to reconfirm GHD at the end of growth in order to select patients with severe GHD who need to resume GH therapy with an appropriate age-related dosage. Some evidence indicates that most peak bone mass (PBM) is achieved by the end of adolescence but small increases in BMD continue during the period of transition from late adolescence to young adulthood. Some young adults with GHD show a persistent increase of lumbar BMD after the completion of growth even after discontinuation of treatment suggesting a spontaneous progression towards lumbar PBM or a continuing effect of the treatment. The data indicates that adolescents with GHD who do not reach lumbar PBM at the time of discontinuation of GH treatment can achieve a BMD lower than their genetic potential if they are not treated during the transition to young adulthood.
authors.affiliation: Department of Reproductive Medicine and Pediatrics, University of Pisa, Pisa, Italy. g.saggese@med.unipi.it
authors.forename: G
authors.initials: G
authors.lastname: Saggese
authors.forename: G I
authors.initials: GI
authors.lastname: Baroncelli
authors.forename: T
authors.initials: T
authors.lastname: Vanacore
authors.forename: L
authors.initials: L
authors.lastname: Fiore
authors.forename: S
authors.initials: S
authors.lastname: Ruggieri
authors.forename: G
authors.initials: G
authors.lastname: Federico
mesh_terms: D000293:Adolescent; D000328:Adult; D001827:Body Height; D015992:Body Mass Index; D015519:Bone Density / Q000187:drug effects*; D001846:Bone Development; D005260:Female; D019382:Human Growth Hormone / Q000172:deficiency* / Q000627:therapeutic use*; D006801:Humans; D008159:Lumbar Vertebrae; D008297:Male; D010349:Patient Compliance; D011788:Quality of Life; D014652:Vascular Diseases / Q000209:etiology / Q000517:prevention & control
chemical_list: D019382:Human Growth Hormone
references.citation: J Clin Endocrinol Metab. 2002 Oct;87(10):4427-8
references.pmid: 12364411
references.citation: Osteoporos Int. 1997;7(6):525-32
references.pmid: 9604047
references.citation: Horm Res. 2002;58 Suppl 1:52-6
references.pmid: 12373015
references.citation: J Bone Miner Res. 1994 Aug;9(8):1319-26
references.pmid: 7976513
references.citation: J Clin Endocrinol Metab. 2000 Mar;85(3):970-6
references.pmid: 10720025
references.citation: J Bone Miner Res. 2001 Feb;16(2):398-405
references.pmid: 11204440
references.citation: Growth Horm IGF Res. 1999 Oct;9(5):290-5
references.pmid: 10543936
references.citation: J Clin Endocrinol Metab. 1996 Aug;81(8):3077-83
references.pmid: 8768878
references.citation: J Clin Endocrinol Metab. 1995 Oct;80(10):3097-8
references.pmid: 7559905
references.citation: J Pediatr Endocrinol Metab. 2000;13 Suppl 6:1337-42
references.pmid: 11202206
references.citation: Osteoporos Int. 1997;7(4):390-406
references.pmid: 9373575
references.citation: J Clin Endocrinol Metab. 2000 Nov;85(11):3990-3
references.pmid: 11095419
references.citation: Growth Horm IGF Res. 1998 Apr;8 Suppl B:177-84
references.pmid: 10990158
references.citation: Clin Endocrinol (Oxf). 2002 Aug;57(2):273-81
references.pmid: 12153608
references.citation: J Clin Endocrinol Metab. 1997 Feb;82(2):352-6
references.pmid: 9024217
references.citation: J Clin Endocrinol Metab. 2000 Oct;85(10):3653-60
references.pmid: 11061518
references.citation: Arch Dis Child. 1987 Mar;62(3):222-6
references.pmid: 3566314
references.citation: Clin Endocrinol (Oxf). 2004 Feb;60(2):175-84
references.pmid: 14725678
references.citation: J Pediatr Endocrinol Metab. 2002 Jun;15(6):809-16
references.pmid: 12099391
references.citation: J Clin Endocrinol Metab. 1997 Aug;82(8):2423-8
references.pmid: 9253311
references.citation: J Appl Physiol Respir Environ Exerc Physiol. 1979 Mar;46(3):451-6
references.pmid: 438011
references.citation: Arch Pediatr. 1997;4(2 Suppl 2):95s-101s
references.pmid: 9246313
references.citation: Horm Res. 2002;58(5):207-14
references.pmid: 12401939
references.citation: Clin Endocrinol (Oxf). 1994 Oct;41(4):511-6
references.pmid: 7955461
references.citation: J Clin Endocrinol Metab. 1985 Mar;60(3):513-6
references.pmid: 3972964
references.citation: J Clin Endocrinol Metab. 2000 Oct;85(10):3693-9
references.pmid: 11061526
references.citation: J Pediatr. 1980 Mar;96(3 Pt 1):393-6
references.pmid: 7359231
references.citation: Drugs. 2002;62(16):2399-412
references.pmid: 12396230
references.citation: J Clin Endocrinol Metab. 1992 Oct;75(4):1060-5
references.pmid: 1400871
references.citation: J Pediatr. 1993 Jan;122(1):37-45
references.pmid: 8419613
references.citation: J Clin Endocrinol Metab. 2002 Aug;87(8):3624-31
references.pmid: 12161486
references.citation: Horm Res. 1997;48 Suppl 5:72-7
references.pmid: 9434048
references.citation: Clin Endocrinol (Oxf). 2001 Nov;55(5):617-24
references.pmid: 11894973
references.citation: J Clin Endocrinol Metab. 1998 Sep;83(9):3150-4
references.pmid: 9745418
references.citation: J Clin Invest. 1994 Feb;93(2):799-808
references.pmid: 8113412
references.citation: Pediatrics. 1999 Oct;104(4 Pt 2):1004-10
references.pmid: 10506252
references.citation: J Clin Endocrinol Metab. 1998 Feb;83(2):382-95
references.pmid: 9467546
references.citation: Horm Res. 1998;50(6):320-40
references.pmid: 9973672
references.citation: J Clin Endocrinol Metab. 1999 Apr;84(4):1324-8
references.pmid: 10199773
references.citation: J Pediatr Endocrinol Metab. 2000;13 Suppl 6:1327-36
references.pmid: 11202205
references.citation: Endocr Rev. 1998 Feb;19(1):55-79
references.pmid: 9494780
references.citation: J Clin Endocrinol Metab. 2001 Apr;86(4):1574-9
references.pmid: 11297586
references.citation: Clin Endocrinol (Oxf). 1996 Mar;44(3):311-6
references.pmid: 8729528
references.citation: Clin Endocrinol (Oxf). 1995 Jan;42(1):3-7
references.pmid: 7889628
references.citation: Arch Dis Child. 1992 Dec;67(12):1472-4
references.pmid: 1489227
references.citation: J Bone Miner Res. 1994 Sep;9(9):1451-8
references.pmid: 7817830
references.citation: J Pediatr Endocrinol Metab. 2002 Dec;15 Suppl 5:1361-5
references.pmid: 12510992
references.citation: Horm Res. 2000;54 Suppl 1:44-51
references.pmid: 11146379
references.citation: J Clin Endocrinol Metab. 1992 Jan;74(1):118-23
references.pmid: 1727808
references.citation: Acta Paediatr Suppl. 1994 Apr;399:3-7; discussion 8
references.pmid: 7949614
references.citation: J Clin Endocrinol Metab. 1999 Jun;84(6):1919-24
references.pmid: 10372687
references.citation: Eur J Endocrinol. 2000 Apr;142(4):347-52
references.pmid: 10754475
references.citation: Clin Endocrinol (Oxf). 1996 Nov;45(5):553-6
references.pmid: 8977751
references.citation: J Clin Endocrinol Metab. 2003 Apr;88(4):1658-63
references.pmid: 12679453
references.citation: J Clin Endocrinol Metab. 1996 Mar;81(3):1248-53
references.pmid: 8772607
references.citation: Clin Endocrinol (Oxf). 2000 Nov;53(5):545-7
references.pmid: 11106913
references.citation: J Clin Endocrinol Metab. 2002 Jan;87(1):90-8
references.pmid: 11788629
references.citation: J Clin Endocrinol Metab. 1996 Apr;81(4):1586-90
references.pmid: 8636372
references.citation: J Clin Endocrinol Metab. 1991 Sep;73(3):555-63
references.pmid: 1874933
references.citation: Endocr Rev. 2001 Aug;22(4):425-50
references.pmid: 11493578
references.citation: J Pediatr Endocrinol Metab. 2000;13 Suppl 6:1343-8
references.pmid: 11202207
references.citation: Eur J Endocrinol. 1997 Sep;137(3):240-5
references.pmid: 9330587
references.citation: J Clin Endocrinol Metab. 2001 Oct;86(10):4765-70
references.pmid: 11600538
references.citation: Scand J Rehabil Med. 1989;21(1):45-53
references.pmid: 2711137
references.citation: J Clin Invest. 1999 Sep;104(6):671-2
references.pmid: 10491399
references.citation: J Clin Endocrinol Metab. 1998 Nov;83(11):3913-9
references.pmid: 9814468
references.citation: Lancet. 1994 Apr 30;343(8905):1064-8
references.pmid: 7512681
references.citation: Clin Endocrinol (Oxf). 1991 Jun;34(6):469-75
references.pmid: 1889131
references.citation: J Clin Endocrinol Metab. 2000 Nov;85(11):4173-81
references.pmid: 11095450
references.citation: Eur J Endocrinol. 2000 Jun;142(6):549-56
references.pmid: 10822216
references.citation: J Pediatr. 1991 Sep;119(3):483-5
references.pmid: 1880667